Literature DB >> 10509596

Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone.

M E Hillebrand-Haverkort, M F Prummel, J H ten Veen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10509596     DOI： 10.1097/00002030-199909100-00038

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

Review 1.  Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.

Authors:  Therdpong Tempark; Voraluk Phatarakijnirund; Susheera Chatproedprai; Suttipong Watcharasindhu; Vichit Supornsilchai; Siriwan Wananukul
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.

Authors:  John E Ray; Debbie Marriott; Mark T Bloch; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

3.  RAPID DEVELOPMENT OF IATROGENIC CUSHING SYNDROME IN A PATIENT ON RITONAVIR: THE ADVERSE METABOLIC CONSEQUENCE OF TOPICAL STEROID USE.

Authors:  Jeremy D Purser; Ruba Riachy; Lucas S Blanton; L Maria Belalcazar
Journal:  AACE Clin Case Rep       Date:  2020-09-24

Review 4.  Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.

Authors:  P Saberi; T Phengrasamy; D P Nguyen
Journal:  HIV Med       Date:  2013-04-16       Impact factor: 3.180

5.  Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals.

Authors:  Kristin H Busse; Elizabeth Formentini; Raul M Alfaro; Joseph A Kovacs; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

6.  Systemic absorption of intranasal corticosteroids may occur and can potentially affect the hypothalamic-pituitary-adrenal axis.

Authors:  Gregory A Kline; Christopher J Symonds; Daniel T Holmes
Journal:  CMAJ       Date:  2021-03-22       Impact factor: 8.262

7.  Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.

Authors:  Narendranath Epperla; Fergus McKiernan
Journal:  Springerplus       Date:  2015-08-27

8.  Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.

Authors:  R Chris Rathbun; Michelle D Liedtke
Journal:  Pharmaceutics       Date:  2011-10-21       Impact factor: 6.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.